PubMed · 8593520
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
S P Lumley, D B McClelland. 1995. Testing tissue donors.. https://doi.org/10.1111/j.1365-3148.1995.tb00224.x
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Five matched pairs of fresh human femurs were used to quantitatively assess the structural integrity of the implanted Wright Medical Technology modular Infinity hip and the Osteonics single-piece Omnifit hip. The results showed that neither bone implant system was able to recreate the femoral anteversion of the intact femur (p < 0.05). Although the micromotion at the bone-implant interface was well within the limits of achieving bone ingrowth, the axial micromotion was greater for the Infinity hip than for the Omnifit hip (p < 0.05), but the rotational micromotion did not show a significant difference between the two bone implant systems (p > 0.5). The anterior proximal femur deformation patterns were similar for both the two bone implant systems and intact femurs. However, the medial proximal femur deformation patterns showed that the Infinity hip-implanted femur was more similar to the intact femur than the Osteonics Omnifit hip-implanted femur.
STUDY DESIGN: Dissection and observation of the dorsal root ganglion of the second cervical spinal nerve bilaterally. OBJECTIVES: To determine the position of the C2 dorsal root ganglion and the heights of the C2 ganglion and its corresponding foramen. SUMMARY OF BACKGROUND DATA: The dorsal root ganglion has been well studied in the middle and lower cervical spine and in the lumbar spine. In no previous study are the position and height of the C2 dorsal root ganglion and its corresponding foramen described. METHODS: Fifteen cadaveric cervical spines were exposed posteriorly. The C2 nerve roots and ganglia were dissected between the arch of the atlas and the lamina of the axis. The heights of the C2 ganglion and foramen were measured. The location of the C2 ganglion was also macroscopically observed. RESULTS: The heights of the C2 ganglion and foramen are 5.7 +/- 0.8 mm and 7.7 +/- 1.2 mm, respectively. The C2 ganglion occupies 76% of the foramen height. All C2 dorsal root ganglia are confined within foramens between the arch of the atlas and the lamina of the axis. CONCLUSIONS: The C2 dorsal dorsal root ganglia are all proximally placed and occupy most of the foramen height, which may render the C2 ganglion vulnerable to entrapment.
BACKGROUND: Nine years ago, a prospective trial began in all U.S. transplant centers to determine whether the results of renal transplantation would improve with the nationwide shipment of kidneys from cadaveric donors to HLA-matched patients. Since then, the stringency of criteria for HLA matching have been liberalized twice, from sharing only those kidneys that matched at all six HLA-A, -B, -DR antigens, to sharing phenotypically HLA-matched kidneys, and most recently to sharing zero HLA-mismatched kidneys. METHODS: Data reported to the United Network for Organ Sharing Scientific Renal Transplant Registry from October 1987 to December 1996 were analyzed to examine the transplant results of nationally shared HLA-matched kidneys and the effects of changes to the HLA matching criteria on graft survival and the distribution of HLA-matched kidneys. RESULTS: The overall 1-year graft survival rate of 5102 HLA-matched transplants was 88% compared with 81% for 58,207 recipients of kidneys with at least one HLA mismatch (P < 0.001). HLA-matched kidneys had a projected 12-year graft half-life, 50% higher than the 8-year half-life of mismatched grafts (P < 0.01). After the first change in the match criteria in August 1990, 1365 phenotypically matched kidneys with fewer than six HLA antigens identified had an 89% 1-year graft survival rate compared with 84% for 466 six antigen-matched kidneys transplanted before the change. After March 1995, 1067 zero HLA-mismatched kidneys that were not phenotypically identical nor six antigen matched, had a 1-year graft survival rate of 88%. Graft survival has not decreased as a result of these changes in the criteria for national sharing, despite an increase in the percentage of matched transplants from 2.5% during the six antigen-match era to 15.5% during the zero antigen-mismatch era. CONCLUSIONS: Changes to the United Network for Organ Sharing policy for national sharing of HLA-matched kidneys have increased the number of patients, and especially minority patients, who can benefit by receiving a well-matched graft without compromising the high graft survival rates provided by an HLA-matched kidney.